Open AccessCost-utility Analysis of Rotavirus Vaccines Including the Latest Evidence and Data as of June 2020 in Japan
Author(s) -
Teruyoshi Kurosawa,
Hiroshi Watanabe,
K. Takahashi
Publication year - 2020
Publication title -
the pediatric infectious disease journal/the pediatric infectious disease journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.028
H-Index - 140
eISSN - 1532-0987
pISSN - 0891-3668
DOI - 10.1097/inf.0000000000002938
Subject(s) - medicine , herd immunity , rotavirus , vaccination , environmental health , pediatrics , immunology , diarrhea
In several health economic analyses of rotavirus vaccines in Japan, all were not cost-effective from the healthcare payer perspective (HPP) but generally cost-effective from the societal perspective (SP). However, few studies have incorporated clinically significant factors of vaccine herd immunity, convulsions with gastroenteritis, encephalopathies, nosocomial infections, death, and intussusception as a vaccine side effect. A cost-utility analysis incorporating these were conducted.